US Stock MarketDetailed Quotes

NeuroSense Therapeutics (NRSN)

Watchlist
  • 0.7900
  • +0.0200+2.60%
Trading Mar 26 12:54 ET
26.38MMarket Cap-2.19P/E (TTM)

NeuroSense Therapeutics (NRSN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-17.82%9.9M
-42.16%1.77M
-19.76%2.11M
-10.09%3.03M
0.10%2.99M
14.17%12.05M
703.67%3.06M
-20.88%2.63M
-6.13%3.37M
-8.36%2.99M
Selling and administrative expenses
-11.96%4.2M
-40.74%685K
14.98%1.23M
-16.50%1.18M
-2.37%1.11M
-3.87%4.78M
446.11%1.16M
-33.79%1.07M
-17.91%1.41M
-42.12%1.14M
-General and administrative expense
-11.96%4.2M
-40.74%685K
14.98%1.23M
-16.50%1.18M
-2.37%1.11M
-3.87%4.78M
446.11%1.16M
-33.79%1.07M
-17.91%1.41M
-42.12%1.14M
Research and development costs
-21.67%5.7M
-43.02%1.09M
-43.58%879K
-5.46%1.85M
1.62%1.88M
30.20%7.27M
166.57%1.91M
-8.68%1.56M
4.71%1.96M
42.90%1.85M
Operating profit
17.82%-9.9M
42.16%-1.77M
19.76%-2.11M
10.09%-3.03M
-0.10%-2.99M
-14.17%-12.05M
-703.67%-3.06M
20.88%-2.63M
6.13%-3.37M
8.36%-2.99M
Net non-operating interest income expense
-14.44%-309K
98.67%-31K
-101.80%-41K
887.32%2.17M
-3,697.01%-2.41M
-421.43%-270K
-159.96%-2.34M
135.12%2.28M
48.31%-276K
-87.80%67K
Non-operating interest income
-98.88%2K
----
----
----
----
95.60%178K
----
----
----
-88.29%67K
Non-operating interest expense
----
----
----
---2.17M
--2.41M
----
----
----
----
----
Total other finance cost
-30.58%311K
-98.69%33K
----
----
----
6,300.00%448K
--2.52M
----
----
----
Other net income (expense)
-99.95%1K
10,154.55%2.21M
Gain on sale of security
-99.95%1K
----
----
----
----
10,154.55%2.21M
----
----
----
----
Income before tax
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
-7.70%-2.92M
Income tax
Net income
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
-7.70%-2.92M
Net income continuous Operations
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
-7.70%-2.92M
Minority interest income
Net income attributable to the parent company
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
-7.70%-2.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
-7.70%-2.92M
Basic earnings per share
27.03%-0.54
68.42%-0.06
-0.11
93.33%-0.02
-40.00%-0.35
18.68%-0.74
-72.73%-0.19
0
3.23%-0.3
-4.17%-0.25
Diluted earnings per share
27.03%-0.54
68.42%-0.06
-0.11
93.33%-0.02
-40.00%-0.35
18.68%-0.74
-72.73%-0.19
0
3.23%-0.3
-4.17%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -17.82%9.9M-42.16%1.77M-19.76%2.11M-10.09%3.03M0.10%2.99M14.17%12.05M703.67%3.06M-20.88%2.63M-6.13%3.37M-8.36%2.99M
Selling and administrative expenses -11.96%4.2M-40.74%685K14.98%1.23M-16.50%1.18M-2.37%1.11M-3.87%4.78M446.11%1.16M-33.79%1.07M-17.91%1.41M-42.12%1.14M
-General and administrative expense -11.96%4.2M-40.74%685K14.98%1.23M-16.50%1.18M-2.37%1.11M-3.87%4.78M446.11%1.16M-33.79%1.07M-17.91%1.41M-42.12%1.14M
Research and development costs -21.67%5.7M-43.02%1.09M-43.58%879K-5.46%1.85M1.62%1.88M30.20%7.27M166.57%1.91M-8.68%1.56M4.71%1.96M42.90%1.85M
Operating profit 17.82%-9.9M42.16%-1.77M19.76%-2.11M10.09%-3.03M-0.10%-2.99M-14.17%-12.05M-703.67%-3.06M20.88%-2.63M6.13%-3.37M8.36%-2.99M
Net non-operating interest income expense -14.44%-309K98.67%-31K-101.80%-41K887.32%2.17M-3,697.01%-2.41M-421.43%-270K-159.96%-2.34M135.12%2.28M48.31%-276K-87.80%67K
Non-operating interest income -98.88%2K----------------95.60%178K-------------88.29%67K
Non-operating interest expense ---------------2.17M--2.41M--------------------
Total other finance cost -30.58%311K-98.69%33K------------6,300.00%448K--2.52M------------
Other net income (expense) -99.95%1K10,154.55%2.21M
Gain on sale of security -99.95%1K----------------10,154.55%2.21M----------------
Income before tax -1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M-7.70%-2.92M
Income tax
Net income -1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M-7.70%-2.92M
Net income continuous Operations -1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M-7.70%-2.92M
Minority interest income
Net income attributable to the parent company -1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M-7.70%-2.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M-7.70%-2.92M
Basic earnings per share 27.03%-0.5468.42%-0.06-0.1193.33%-0.02-40.00%-0.3518.68%-0.74-72.73%-0.1903.23%-0.3-4.17%-0.25
Diluted earnings per share 27.03%-0.5468.42%-0.06-0.1193.33%-0.02-40.00%-0.3518.68%-0.74-72.73%-0.1903.23%-0.3-4.17%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospects of a ceasefire negotiation between the US and Iran have been dominating market sentiment. On March 26, Eastern Time, Show More